News
Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient ...
Prefilled syringe presentation offers a convenient administration option to healthcare professionals· An estimated one million people develop shingles in the US each year[1]GSK plc ...
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Frauenfeld, 17 July 2025Press releaseAd hoc announcement pursuant ...
The global surgical robots market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...
The US child care market is set to witness a growth rate of 6% in the next 5 years. Increased workforce participation by ...
Two groundbreaking drug discovery projects, supported by Medicines Discovery Catapult (MDC), have secured over £1m in funding ...
Global Drug Discovery Services Market Expected to Expand at 15% CAGR Due to Chronic Diseases by 2030
The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by the increasing demand for outsourced drug discovery activities, advancements ...
New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapiesCORALVILLE, Iowa ...
The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
IPO/MergerXlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 17.07.2025 / 07:00 CET/CESTThe filing demonstrates continued momentum ...
Investment/Mergers & Acquisitions17-Jul-2025 / 06:59 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback